Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(19/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(19/week)
News
United States
(450/week)
Manufacturing
(348/week)
Technology
(352/week)
Energy
(230/week)
Other Manufacturing
(292/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Eli Lilly and Company
Nov 19, 2020
Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19
Nov 18, 2020
Jardiance® reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME® trial
Nov 12, 2020
Lilly to Participate in Bernstein Operational Decisions Conference
Nov 12, 2020
Lilly to Participate in Wolfe Research Virtual Healthcare Conference
Nov 11, 2020
Lilly Announces Webcast to Provide an Overview of Tirzepatide Phase 3 clinical program
Nov 09, 2020
Lilly's neutralizing antibody bamlanivimab (LY-CoV555) receives FDA emergency use authorization for the treatment of recently diagnosed COVID-19
Nov 05, 2020
Aarti Shah to Retire as Lilly Chief Information and Digital Officer
Nov 05, 2020
Loxo Oncology at Lilly Announces Details of LOXO-305 Presentations at the 2020 American Society of Hematology (ASH) Annual Meeting
Nov 02, 2020
ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant® in Rheumatoid Arthritis
Oct 31, 2020
EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment of Moderate to Severe Atopic Dermatitis
Oct 30, 2020
Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for Baricitinib in Adult Patients with Alopecia Areata
Oct 29, 2020
New Data at EADV 2020 Confirm Taltz® (ixekizumab) Demonstrates Sustained Long-Term Efficacy in Patients with Psoriasis and Psoriatic Arthritis
Oct 28, 2020
Lilly announces agreement with U.S. government to supply 300,000 vials of investigational neutralizing antibody bamlanivimab (LY-CoV555) in an effort to fight COVID-19
Oct 28, 2020
Data for Lilly's bamlanivimab (LY-CoV555) in COVID-19 outpatients published in New England Journal of Medicine
Oct 23, 2020
New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status
Oct 21, 2020
Docbot Announces Results of Study Evaluating Deep Learning Platform for Ulcerative Colitis Published in Journal, Gastroenterology
Oct 19, 2020
Lilly Declares Fourth-Quarter 2020 Dividend
Oct 15, 2020
Lilly Announces Agreement to Acquire Disarm Therapeutics
Oct 12, 2020
Mirikizumab Shows Continued Symptom Improvement and Reduction of Intestinal Inflammation in Patients with Crohn's Disease in 52-Week Phase 2 Trial
Oct 09, 2020
Lilly's OVERCOME Study Reveals Nearly 80% of People Reported Improvement in Their Migraine Since Starting a CGRP Monoclonal Antibody for Preventive Treatment
‹‹
Page 3
››
Latest News
Mar 29, 2024
Anaergia Announces Delay in the Filing of Its Audited Financial Statements and Related Disclosures
Mar 29, 2024
Anaergia Announces Escrow Closing of Second Tranche of the Strategic Investment
Mar 29, 2024
Midea Group releases its first-ever ESG brand story with an unexpected VIP visit highlighting its commitment...
Mar 29, 2024
Cool Company Ltd. - Announcement Of Filing Of Form 20-F Annual Report
Mar 29, 2024
dynaCERT Provides Update on the Purchase Order for HydraGEN™ Units Destined for Guyana
Mar 29, 2024
CFIUS Accepts Re-filed Notice for Proposed Sale of The Kinetic Group to CSG
Mar 29, 2024
Cheniere Energy Partners, L.P. 2023 Annual Report
Mar 29, 2024
Aptiv to Release First Quarter 2024 Financial Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events